1.
Pece R, Tavella S, Costa D, Varesano S, Camodeca C, Cuffaro D, Nuti E, Rossello A, Alfano M, D’Arrigo C, Galante D, Ravetti J-L, Gobbi M, Tosetti F, Poggi A, Zocchi MR. Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect. haematol [Internet]. 2021Jun.10 [cited 2022Sep.28];107(4):909-20. Available from: https://haematologica.org/article/view/haematol.2021.278469